Research from the University of Michigan Health and the University of Rochester reveals that selective attention does not involve sound being processed differently at the subcortical level.

Serious mental illnesses (SMI) take a tremendous toll on individuals, their friends and family, and society as a whole. SMI such as schizophrenia, bipolar disorder, and major depressive disorder contribute to poverty, unemployment, and homelessness, and can lead to hospitalization and suicide. Predicting when intensive intervention is needed in individual cases is a major unmet mental healthcare need.

Cannabidiol may target proinflammatory mechanisms to reduce neuroinflammation in an Alzheimer’s mouse model, offering a new potential therapeutic approach.

Internal organ tissues often don’t heal after illness or injury and lose some function, such as the heart after a heart attack. UCLA cardiologists have identified a protein that interferes with healing. Funded entirely by federal and state grants, the researchers developed a drug to block this protein and promote tissue regeneration. The FDA has now granted approval to begin Phase I clinical trials of the first-in-class drug for tissue repair, called AD-NP1, in humans.

Researchers from Michigan State University’s Department of Psychology are examining the understudied period of perimenopause and its potential impacts on mental health thanks to a $3.7 million grant from the National Institute of Mental Health.